We're about to get a heavy helping of MCP from the keynote stage, as fuel for the agentic AI buzz. But why MCP? Why is ...

Rajesh Balachandran, CMO, Muthoot FinCorp, shares how the brand is balancing tradition with technology, regional resonance ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but also how technology has allowed for quick and now cheap ways of mapping ...

The overwhelming majority of generative AI programs have so far failed to deliver significant business returns. Research ...